1. |
Rubin BP, Heinrich MC, Corless CL. Gastrointestinal stromal tumour. J Lancet, 2007, 369(9574): 1731-1741.
|
2. |
Demetri GD, Benjamin RS, Blanke CD, et al. NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw, 2007, 5(Suppl 2): S1-29.
|
3. |
錢紅綱, 郝純毅. 胃腸間質瘤復發和轉移的治療. 中國實用外科雜志, 2010, (4): 281-285.
|
4. |
Schubert ML, Moghimi R. Gastrointestinal stromal tumor (GIST). Curr Treat Options Gastroenterol, 2006, 9(2): 181-188.
|
5. |
鄧愛平, 王成林. 胃腸間質瘤X診斷(附5例分析). 罕少疾病雜志, 2007, 14(6): 8-10.
|
6. |
Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol, 2008, 39(10): 1411-1419.
|
7. |
Cancer Therapy Evaluation Program. Common toxicity criteria manual:common toxicity criteria, version 3.0[G]. Behesda, Md: National Cancer Institute, April 10 2003.
|
8. |
Stamatakos M, Douzinas E, Stefanaki C, et al. Gastrointestinal stromal tumor. World J Surg Oncol, 2009, 7: 61.
|
9. |
Corless CL, Fletcher JA, Heinrich MC. Biology of gastrointestinal stromal tumors. J Clin Oncol, 2004, 22(18): 3813-3125.
|
10. |
DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for surviva1. Ann Surg, 2000, 23 1(1): 51-58.
|
11. |
D’Amato G, Steinert DM, McAulifie JC, et al. Update on the biology and therapy of gastrointestinal stromal tumors. Cancer Control, 2005, 12(1): 44-56.
|
12. |
Heinrich MC, Griffith DJ, Druker BJ, et al. Inhibition of c-kit receptor tyrosine kinase activity by STI571, a selective tyrosine kinase inhibitor. Blood, 2000, 96(3): 925-932.
|
13. |
Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med, 2001, 344(14): 1052-1056.
|
14. |
Dematteo RP, Ballman KV, Antonescu CR, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet, 2009, 373(9669): 1097-1104.
|
15. |
蔡成機. 胃腸間質瘤的診治理念. 中國普通外科雜志, 2007, 16(9): 887-889.
|
16. |
龔軍, 彭彬, 黃義明, 等. 胃腸間質瘤9例臨床分析. 醫師進修雜志, 2005, 28(11): 36-37.
|
17. |
龔勛, 陳宗佑, 項建斌. 胃腸間質瘤診斷與治療進展. 國際外科學雜志, 2008, 35(3): 177-180.
|
18. |
黃權. 32例胃腸間質瘤的診斷與外科治療. 廣西醫科大學學報, 2010, 27(4): 625-626.
|
19. |
Iwahashi M, Takifuji K, Ojima T, et al. Surgical management of small gastrointestinal stromal tumors of the stomach. World J Surg, 2006, 30(1): 28-35.
|
20. |
. 陸琪, 李蔚萍, 程愛群, 等. 胃腸問質瘤87例臨床分析. 中國實用外科雜志, 2010, 30(4): 301-303.
|
21. |
. 詹文華, 王鵬志, 邵永孚, 等. 伊馬替尼術后輔助治療胃腸間質瘤的多中心前瞻性臨床試驗中期報告. 中華胃腸外科雜志, 2006, 9(5): 383-387.
|